Internal Medicine, Hematology · Boston, MA
NPI
1457342024
Since 2005
Specialty
Internal Medicine, Hematology
Code 207RH0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
55 Fruit St, Yaw 7b Hematology Oncology
Boston, MA, 02114
Phone (617) 724-6193
Groups this clinician bills Medicare through
Medicare paid, 2024
$70K
1,053 services
Medicare patients, 2024
350
Average age 75
Drug cost, 2024
$4.0M
615 prescriptions
Company payments, 2025
$75K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David J Kuter was code 99215 (office e&m - established), 318 times for 213 patients. In total David J Kuter billed 1,053 services in 6 codes, and Medicare paid $70K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 318 | 213 | $108.70 | $35K |
| 99215 Office E&M - Established | Office | 217 | 142 | $112.20 | $24K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 200 | 155 | $13.61 | $2,723 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 140 | 113 | $13.11 | $1,835 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Facility | 120 | 85 | $24.58 | $2,949 |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 33 | 26 | $24.26 | $800 |
By year: 2022 $82K for 901 services; 2023 $74K for 783 services; 2024 $70K for 1,053 services.
Medicare prescription drug claims, 2024
In 2024, the drug David J Kuter prescribed most often to Medicare patients was Hydroxyurea, with 135 prescriptions and refills. In total David J Kuter wrote 615 Medicare prescriptions that cost $4.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxyurea Generic | 135 | 385 | 46 | $4,647 |
| Jakafi Ruxolitinib Phosphate | 123 | 123 | 16 | $1.9M |
| Eliquis Apixaban | 96 | 231 | 37 | $130K |
| Xarelto Rivaroxaban | 72 | 176 | 23 | $96K |
| Imbruvica Ibrutinib | 34 | 34 | Under 11 | $420K |
| Prednisone Generic | 27 | 59 | 14 | $444 |
| Doptelet Avatrombopag Maleate | 23 | 23 | Under 11 | $430K |
| Fondaparinux Sodium Generic | 19 | 33 | Under 11 | $25K |
| Cerdelga Eliglustat Tartrate | 16 | 16 | Under 11 | $493K |
| Retacrit Epoetin Alfa-Epbx | 12 | 12 | Under 11 | $41K |
Brand drugs: 417 claims; generic drugs: 198 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David J Kuter $75K ($70K in general payments such as food, travel and fees and $4,320 for research) from 12 companies. The largest payer was Novartis Pharmaceuticals Corporation with $30K.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 15 | $30K |
| Genzyme Corporation SNY | 13 | $20K |
| Alexion Pharmaceuticals, Inc. AZN | 14 | $12K |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $4,270 |
| Merck Sharp & Dohme LLC MRK | 4 | $3,203 |
| Recordati_rare_diseases_inc. | 2 | $2,397 |
| Novartis Pharma AG NVS | 2 | $1,037 |
| Chugai Pharmaceutical Co., Ltd. 4519.T | 1 | $760 |
| Sobi, Inc SOBI.ST | 1 | $139 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $102 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.